Gastroenterology
0 drugs are in development for Nonalcoholic Steatohepatitis.
- Companies
- 0
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Nonalcoholic Steatohepatitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Nonalcoholic Steatohepatitis context
Gastroenterology·MeSH: Non-alcoholic Fatty Liver Disease (D065626)
Narrower concept of MeSH descriptor NAFLD
Prevalence
5000.0 / 100K
Incidence
500.0 / 100K/yr
Frequently asked questions
How many clinical trials target Nonalcoholic Steatohepatitis?
There are 5 clinical trials targeting Nonalcoholic Steatohepatitis tracked by BioSniper.
What is the prevalence of Nonalcoholic Steatohepatitis?
The estimated prevalence of Nonalcoholic Steatohepatitis is approximately 5000.0 per 100,000 population.